“Neuro-diverse: A Symposium on Autism, Neuroscience and Perceptual Thinking” and an associated evening lecture – both free and open to the public – will take place on the Vanderbilt campus Monday, May 23.

Collybolide – a natural product isolated from a mushroom – is a promising candidate for the development of non-addictive pain medicines.

Elizabeth Ennis, Graduate School, Gregory LaChaud, School of Medicine, and Amy Bonau, School of Nursing, are among those taking part in Commencement exercises on Friday, May 13.

It is widely assumed that individuals with autism spectrum disorder (ASD) are insensitive to pain due to the wide prevalence of self-injurious behaviors. A new study at Vanderbilt University Medical Center suggests that this may not be true.

Vanderbilt University Medical Center (VUMC) has again been named among the “100 Great Hospitals in America” by Becker’s Hospital Review.

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, spoke about his lab’s research linking metabolism to stem cell maintenance during his recent Flexner Discovery Lecture.